317 related articles for article (PubMed ID: 29988733)
1. Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine.
Xiong W; Sang W; Linghu KG; Zhong ZF; Cheang WS; Li J; Hu YJ; Yu H; Wang YT
Int J Nanomedicine; 2018; 13():3781-3793. PubMed ID: 29988733
[TBL] [Abstract][Full Text] [Related]
2. Brij-functionalized chitosan nanocarrier system enhances the intestinal permeability of P-glycoprotein substrate-like drugs.
Xiong W; Xiong SH; Chen QL; Linghu KG; Zhao GD; Chu JMT; Wong GTC; Li J; Hu YJ; Wang YT; Yu H
Carbohydr Polym; 2021 Aug; 266():118112. PubMed ID: 34044929
[TBL] [Abstract][Full Text] [Related]
3. Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: part 2. development of oral dosage formulations.
Murakami T; Bodor E; Bodor N
Expert Opin Drug Metab Toxicol; 2023 Mar; 19(3):139-148. PubMed ID: 37060323
[TBL] [Abstract][Full Text] [Related]
4. Natural Nano-Drug Delivery System in
Zhao J; Zhao Q; Lu JZ; Ye D; Mu S; Yang XD; Zhang WD; Ma BL
Int J Nanomedicine; 2021; 16():6297-6311. PubMed ID: 34552326
[TBL] [Abstract][Full Text] [Related]
5. Baicalin-berberine complex nanocrystals orally promote the co-absorption of two components.
Li Z; Liu Y; Wang J; Feng X; Nwafor EO; Zhang Y; Liu R; Dang W; Zhang Q; Yu C; Pi J; Liu Z
Drug Deliv Transl Res; 2022 Dec; 12(12):3017-3028. PubMed ID: 35476182
[TBL] [Abstract][Full Text] [Related]
6. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.
Zhang Z; Chen Y; Deng J; Jia X; Zhou J; Lv H
Int J Pharm; 2014 Apr; 465(1-2):306-16. PubMed ID: 24456672
[TBL] [Abstract][Full Text] [Related]
7. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
[TBL] [Abstract][Full Text] [Related]
8. MgAl monolayer hydrotalcite increases the hypoglycemic effect of berberine by enhancing its oral bioavailability.
Wang A; Yang W; Yang X; Mei X; Hu T; Liang R; Meng D; Yan D
Biomed Pharmacother; 2020 Jul; 127():110140. PubMed ID: 32380387
[TBL] [Abstract][Full Text] [Related]
9. Enhancing effects of chitosan and chitosan hydrochloride on intestinal absorption of berberine in rats.
Chen W; Fan D; Meng L; Miao Y; Yang S; Weng Y; He H; Tang X
Drug Dev Ind Pharm; 2012 Jan; 38(1):104-10. PubMed ID: 21774632
[TBL] [Abstract][Full Text] [Related]
10. Self-nanoemulsifying system improves oral absorption and enhances anti-acute myeloid leukemia activity of berberine.
Li J; Yang L; Shen R; Gong L; Tian Z; Qiu H; Shi Z; Gao L; Sun H; Zhang G
J Nanobiotechnology; 2018 Oct; 16(1):76. PubMed ID: 30290822
[TBL] [Abstract][Full Text] [Related]
11. Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles.
Xue M; Yang MX; Zhang W; Li XM; Gao DH; Ou ZM; Li ZP; Liu SH; Li XJ; Yang SY
Int J Nanomedicine; 2013; 8():4677-87. PubMed ID: 24353417
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of P-glycoprotein by HIV protease inhibitors increases intracellular accumulation of berberine in murine and human macrophages.
Zha W; Wang G; Xu W; Liu X; Wang Y; Zha BS; Shi J; Zhao Q; Gerk PM; Studer E; Hylemon PB; Pandak WM; Zhou H
PLoS One; 2013; 8(1):e54349. PubMed ID: 23372711
[TBL] [Abstract][Full Text] [Related]
13. Improvement of intestinal transport, absorption and anti-diabetic efficacy of berberine by using Gelucire44/14: In vitro, in situ and in vivo studies.
Sun J; Bao H; Peng Y; Zhang H; Sun Y; Qi J; Zhang H; Gao Y
Int J Pharm; 2018 Jun; 544(1):46-54. PubMed ID: 29654898
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
15. Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability.
Khan MA; Ansari MM; Arif ST; Raza A; Choi HI; Lim CW; Noh HY; Noh JS; Akram S; Nawaz HA; Ammad M; Alamro AA; Alghamdi AA; Kim JK; Zeb A
Drug Deliv; 2021 Dec; 28(1):2510-2524. PubMed ID: 34842018
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats.
Chen W; Miao YQ; Fan DJ; Yang SS; Lin X; Meng LK; Tang X
AAPS PharmSciTech; 2011 Jun; 12(2):705-11. PubMed ID: 21637946
[TBL] [Abstract][Full Text] [Related]
17. Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid.
Godugu C; Patel AR; Doddapaneni R; Somagoni J; Singh M
PLoS One; 2014; 9(3):e89919. PubMed ID: 24614362
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of oral bioavailability of 20(S)-ginsenoside Rh2 through improved understanding of its absorption and efflux mechanisms.
Yang Z; Gao S; Wang J; Yin T; Teng Y; Wu B; You M; Jiang Z; Hu M
Drug Metab Dispos; 2011 Oct; 39(10):1866-72. PubMed ID: 21757611
[TBL] [Abstract][Full Text] [Related]
19. Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: Part 1. Physicochemical and pharmacokinetic properties.
Murakami T; Bodor E; Bodor N
Expert Opin Drug Metab Toxicol; 2023 Mar; 19(3):129-137. PubMed ID: 37057922
[TBL] [Abstract][Full Text] [Related]
20. Rod-shaped nintedanib nanocrystals improved oral bioavailability through multiple intestinal absorption pathways.
Zhu Y; Fu Y; Zhang A; Wang X; Zhao Z; Zhang Y; Yin T; Gou J; Wang Y; He H; Tang X
Eur J Pharm Sci; 2022 Jan; 168():106047. PubMed ID: 34687899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
